Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
86,723,804
-
Total 13F shares
-
1,840,525
-
Share change
-
+586,842
-
Total reported value
-
$5,505,585
-
Price per share
-
$3.01
-
Number of holders
-
26
-
Value change
-
+$1,681,256
-
Number of buys
-
10
-
Number of sells
-
6
Institutional Holders of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) as of Q4 2023
As of 31 Dec 2023,
Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,840,525 shares.
The largest 10 holders included
LEVIN CAPITAL STRATEGIES, L.P., MORGAN STANLEY, HoyleCohen, LLC, Corbin Capital Partners, L.P., HighTower Advisors, LLC, Atalaya Capital Management LP, SATOVSKY ASSET MANAGEMENT LLC, Private Advisor Group, LLC, Mariner, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.